NP / PA
Valley Cancer Associates PA
Valley Cancer Associates PA was paid $1.33M by Medicaid between Jan 2018 and Dec 2024, across 49 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoVALLEY CANCER ASSOCIATES PA
HARLINGEN, TX 78550
HARLINGEN, TX 78550
33aNPI1427233238assigned 12/31/2007
33bProvider typePhysician Assistant
28Total paid$1.33M
24GClaims133,234
24DCodes billed49
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Physician Assistant providers in Texas
Rank by total paid#28 of 161
Median peer was paid$43K
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,280 | $62K | |
| 2019 | 16,240 | $62K | |
| 2020 | 18,256 | $159K | |
| 2021 | 26,893 | $313K | |
| 2022 | 23,465 | $294K | |
| 2023 | 19,024 | $285K | |
| 2024incomplete | 12,076 | $161K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 18,340 | 15,092 | $363K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 15% | 8,713 | 1,572 | $202K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 11% | 2,522 | 1,674 | $150K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 6.8% | 3,539 | 1,621 | $90K |
| 80053 | Comprehensive metabolic panel | 6.3% | 22,986 | 17,897 | $84K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.7% | 23,498 | 18,090 | $63K |
| J0490 | Injection, belimumab, 10 mg | 3.5% | 19 | 12 | $47K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3.1% | 4,625 | 2,126 | $41K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.0% | 3,760 | 3,045 | $40K |
| 99223 | Prolong inpt eval add15 m | 2.9% | 755 | 700 | $39K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.8% | 2,157 | 861 | $37K |
| J1756 | Injection, iron sucrose, 1 mg | 2.7% | 1,191 | 547 | $36K |
37 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.6% | 6,390 | $35K |
| 96367 | 2.0% | 2,026 | $27K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | 1.6% | 471 | $21K |
| 86300 | 1.4% | 2,559 | $18K | |
| 82728 | <1% | 2,021 | $10K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 218 | $8K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,707 | $3K |
| 96417 | <1% | 66 | $3K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 603 | $2K |
| 96415 | <1% | 111 | $2K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 3,013 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 71 | $2K |
| 81003 | <1% | 1,335 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,628 | $980.45 |
| 81001 | <1% | 1,070 | $857.81 | |
| 52000 | <1% | 14 | $710.90 | |
| 0011A | <1% | 28 | $570.82 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 961 | $511.54 |
| 0012A | <1% | 20 | $400.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 382 | $375.74 |
| 85610 | <1% | 97 | $205.20 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 74 | $201.94 |
| 90674 | <1% | 30 | $185.50 | |
| 85651 | <1% | 76 | $175.91 | |
| 90688 | <1% | 16 | $144.48 | |
| 82378 | <1% | 38 | $143.37 | |
| 84436 | <1% | 26 | $86.55 | |
| 90686 | <1% | 25 | $70.08 | |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | <1% | 52 | $65.62 |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,804 | $10.07 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 21 | $0.00 |
| G8731 | Pain assessment using a standardized tool is documented as negative, no follow-up plan required | 0% | 22 | $0.00 |
| 4040F | 0% | 21 | $0.00 | |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 22 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 49 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 40 | $0.00 |
| 1123F | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHARRISON, MARK (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| University Pediatricians | Detroit, MI | $107.02M |
| University Pediatricians Autism Center | Novi, MI | $9.14M |
| University Pediatricians | Detroit, MI | $2.01M |
| Mark R Harrison DDS PA | Exeter, NH | $66K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.